FDA approves nexium for use in children ages 1-11 years.
Lang
Les
L
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004304:Dosage Forms / Q000592:standards; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D064098:Esomeprazole / Q000008:administration & dosage / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D004304:Dosage Forms; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064098:Esomeprazole